Various therapies are under development targeting IAPs and in particular XIAP and survivin in a number of malignancies (10) and we wanted to investigate in detail the potential of such therapies in mesothelioma using a panel of cell lines. This evidence concerns the gene BIRC5 and mesothelioma.